시장보고서

상품코드

1646499

주입 기기 시장 규모 및 예측(2021-2031년) - 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 제품 유형별, 용도별, 최종사용자별, 지역별

Infusion Devices Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Geography

발행일: 2025년 01월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 216 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

주입 기기 시장은 2023년 137억 3,000만 달러에서 2031년까지 230억 8,000만 달러에 달할 것으로 예상되며, 2023년부터 2031년까지 CAGR은 6.7%로 추정됩니다. 시장 성장을 촉진하는 주요 요인으로는 암 유병률의 증가와 노인 인구의 증가를 들 수 있습니다. 또한, 시장 진입 기업들의 전략적 노력이 예측 기간 동안 시장을 견인할 것으로 예상됩니다. 그러나 주입 기기의 빈번한 제품 회수는 시장 억제요인 중 하나입니다.

헬스케어의 발전은 전 세계 평균 수명의 증가를 가져왔고, 이는 전 세계 노인 인구의 증가로 이어지고 있습니다. 미국 인구조사국에 따르면 미국의 65세 이상 인구는 2022년 5,800만 명에서 2050년까지 8,200만 명으로 47% 증가할 것으로 예상됩니다. 또한 미국에서는 65세 이상 인구가 전체 인구에서 차지하는 비율은 2022년 17%에서 2050년 23%로 증가할 것으로 예측됩니다. 캐나다 통계청에 따르면, 캐나다에서는 2022년 약 5명 중 1명(인구의 18.8%, 732만 9910명)이 65세 이상이며, 2022년에는 캐나다 인구의 약 20%가 65세 이상입니다. 또한, 인구 예측에 따르면 2068년에는 캐나다 국민의 21%에서 29%가 65세 이상이 될 것으로 추정됩니다.

WHO에 따르면, 2030년까지 전 세계 6명 중 1명이 60세 이상이 될 것이며, 2020년에는 10억 명이 60세 이상이 되었으며, 2030년에는 14억 명, 2050년에는 21억 명에 달할 것으로 예상됩니다. 중저소득 국가에 거주하게 될 것이라고 밝혔습니다. 또한 인구문제연구소에 따르면 아시아와 유럽이 가장 고령화가 빠르게 진행되고 있습니다. 일본은 노인 인구의 28%로 1위, 이탈리아가 23%로 그 뒤를 잇고 있습니다. 핀란드, 포르투갈, 그리스는 노인 인구가 약 22%인 상위 5개국입니다.

노인 인구에 대한 수액 요법의 주요 이점은 다음과 같습니다.

수분 보충 및 전해질 균형 : 노인은 수분 섭취 의욕 저하, 특정 약물, 신장 기능의 변화 등의 요인으로 인해 탈수 위험이 높아질 수 있습니다. 정맥주사는 노인이 전반적인 건강을 위해 필요한 수분과 전해질 수준을 유지하는 데 도움이 될 수 있습니다.

영양 상태 개선 : 나이가 들어감에 따라 필요한 영양소의 섭취와 흡수가 어려워져 만성질환의 위험이 증가합니다. 수액 요법은 필수 미네랄, 비타민, 아미노산을 효율적으로 혈류에 공급하여 영양 섭취 과정을 완화합니다.

면역 기능 강화 : 나이가 들면 감염에 걸리기 쉬워지기 때문에 면역 체계는 특별한 지원이 필요합니다. 수액 요법은 비타민 C, 아연, 글루타티온과 같은 면역력 강화 영양소를 체내에 직접 공급할 수 있습니다.

통증 관리 : 노인들은 만성 통증으로 인해 삶의 질에 영향을 받고 있습니다. 수액 요법은 약물을 혈류에 직접 주입하여 염증을 억제하고 통증을 완화함으로써 신속하고 효과적으로 통증을 관리할 수 있습니다.

이처럼 노인 인구의 증가는 전 세계적으로 주입 기기에 대한 수요를 견인하고 있습니다.

경쟁사별 분석은 제품 포트폴리오(제품 만족도, 제품 특징, 가용성), 최근 시장 동향(인수합병, 신제품 출시 및 강화, 투자 및 자금 조달, 수상, 계약, 제휴 및 파트너십, 인지도, 확장), 그리고 경쟁 상황을 더 잘 이해하고 의사결정을 내리는 데 도움이 되는 지역적 존재를 바탕으로 주입 주입 장치 시장을 평가하고 분류하고 있습니다. 이 보고서는 세계 주입 기기 시장의 주요 벤더들의 최근 주요 동향과 혁신에 대해 심층적으로 조사했습니다. 주요 시장 기업은 Becton Dickinson and Co, Fresenius Kabi AG, B Braun SE, CODAN US Corp, Baxter International Inc, Elimedical Inc, ICU Medical Inc, BPL Medical Inc, BPL Medical Inc, Nipro Medical Inc. Technologies Pvt Ltd, Nipro Corp, KD Scientific Inc, Medtronic Plc, Zimed Healthcare Ltd, Terumo Corp, Eitan Medical Ltd, Polymedicure, Moog Inc, Tandem Diabetes Care Inc. Tandem Diabetes Care Inc.입니다.

제품 유형별로 주입 기기 시장은 수액 펌프와 수액 세트로 구분되며, 2023년에는 수액 펌프 부문이 가장 큰 시장 점유율을 차지했습니다. 주입 펌프 부문은 용량 펌프, 주사기 펌프, 주사기 펌프, 인슐린 펌프, 환자 제어 진통제(PCA) 펌프, 장내 펌프, 임플란트 펌프, 엘라스토머 펌프로 세분화됩니다. 수액 세트 분야는 통기성 수액 세트와 비통기성 수액 세트로 세분화됩니다. 용도별로 주입 기기 시장은 당뇨병, 종양, 통증 관리, 혈액, 소아과, 소화기, 기타로 분류되며, 2023년에는 당뇨병 분야가 가장 큰 시장 점유율을 차지했습니다.

주입 기기 시장에서 사업을 전개하는 기업들은 다양한 유기적, 무기적 전략을 채택하고 있습니다. 유기적 전략에는 주로 제품 출시와 제품 승인이 포함됩니다. 무기적 성장 전략으로는 인수, 제휴, 파트너십 등을 들 수 있습니다. 이러한 성장 전략을 통해 시장 진입 기업은 사업을 확장하고, 지리적 입지를 강화하며, 전체 시장 성장에 기여할 수 있습니다. 또한, 인수 및 제휴와 같은 전략은 고객 기반을 강화하고 제품 포트폴리오를 확장하는 데 도움이 됩니다. 주입 기기 시장의 주요 업체들의 주요 발전은 다음과 같습니다.

2024년 5월, Moog Inc.는 CURLIN 8000 Ambulatory Infusion System의 미국 FDA 510(k) 승인을 획득했습니다. 이 프리미엄 수액 플랫폼은 재택 수액 환경에서 사용하기 위해 특별히 개발되었으며, CURLIN 8000은 신뢰할 수 있는 견고한 설계와 임상 및 비임상 사용자 모두가 쉽게 조작할 수 있도록 설계된 단순하고 직관적인 사용자 인터페이스를 결합하여 결합되어 있습니다. 또한, CURLIN 8000은 기존 재택 수액 워크플로우를 보완하기 위해 개발된 완전히 새로운 약물 안전성 소프트웨어인 CURLIN RxManager와 완벽하게 통합됩니다.

주입 기기 시장 - 주요 시장 역학
시장 성장 촉진요인
- 암 유병률 증가
- 노인 인구 증가
시장 성장 억제요인
- 주입 기기의 빈번한 제품 회수
시장 기회
- 전략적 대처 : 시장 기업별
향후 동향
- 높아지는 기술 진보
성장 촉진요인과 억제요인의 영향

제6장 주입 기기 시장 : 세계 시장 분석

주입 기기 시장 매출, 2021-2031년
주입 기기 시장 예측 분석

제7장 주입 기기 시장 분석 - 제품 유형별

주입 펌프
주입 세트

제8장 주입 기기 시장 분석 - 용도별

당뇨병
종양학
통증 관리
혈액학
소아과
소화기내과
기타

제9장 주입 기기 시장 분석 - 최종사용자별

병원·전문 클리닉
재택의료
외래 수술 센터
기타

제10장 주입 기기 시장 - 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 그 아시아태평양
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제11장 업계 상황

주입 기기 시장의 성장 전략
유기적 성장 전략
무기적 성장 전략
- 성장 전략

제12장 기업 개요

Becton Dickinson and Co
Fresenius Kabi AG
B Braun SE
CODAN US Corp
Baxter International Inc
Elimedical Inc
ICU Medical Inc
BPL Medical Technologies Pvt Ltd
Nipro Corp
KD Scientific Inc
Medtronic Plc
Zimed Healthcare Ltd
Terumo Corp
Eitan Medical Ltd
Polymedicure
Moog Inc
Tandem Diabetes Care Inc

제13장 부록

ksm 25.02.27

The infusion devices market is expected to reach US$ 23.08 billion by 2031 from US$ 13.73 billion in 2023; the market is estimated to grow at a CAGR of 6.7% during 2023-2031. Major factors driving the market growth include increasing prevalence of cancer and growing geriatric population. Further, strategic initiatives by market players are likely to boost the market during the forecast period. However, frequent product recalls of infusion devices are among the market deterrents.

Advancements in healthcare are increasing life expectancy globally, leading to a global rise in the geriatric population. According to the US Census Bureau, the number of people in the US aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, in the US, the percentage of the total population of 65 and above is projected to rise from 17% in 2022 to 23% in 2050. According to Statistics Canada, approximately one in five people in Canada (i.e., 18.8% of the population or 7,329,910 people) were at least 65 in 2022. In 2022 approximately 20% of the population in Canada is aged 65 years and above. Furthermore, population projections suggest that 21-29% of the people in Canada are estimated to be aged 65 or above by 2068.

As per the WHO, by 2030, one in 6 people in the world will be 60 years or more. One billion people were reported to be 60 and above in 2020 and the number is expected to reach 1.4 billion in 2030 and 2.1 billion by 2050. WHO also stated that by 2050, 80% of older people will be living in low- and middle-income countries. Additionally, as per the Population Reference Bureau, Asia and Europe have the oldest population. Japan ranks first with 28% of geriatric population, followed by Italy with 23%. Finland, Portugal, and Greece are among the top five countries with ~22% of geriatric population.

A few key benefits of infusion therapy used for geriatric populations are listed below.

Rehydration and Electrolyte Balance: Dehydration can be a higher risk for older people due to factors such as decreased urge to drink fluids, certain medications, and changes in kidney function. IV fluids help seniors maintain the necessary hydration and electrolyte levels for overall health.

Improved Nutritional Status: Consumption and absorption of the required nutrient become challenging with age, increasing the risk of chronic illnesses. Infusion therapy provides essential minerals, vitamins, and amino acids efficiently into the bloodstream and eases the process of nutrient uptake.

Enhanced Immune Function: Immune systems need extra support at an older age as they become more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.

Pain Management: The senior population majorly suffers from chronic pain, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, reducing inflammation and providing relief.

Thus, the increasing geriatric population drives the demand for infusion devices across the globe

The comparative company analysis evaluates and categorizes the infusion devices market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Infusion Devices Market. The key market players are Becton Dickinson and Co, Fresenius Kabi AG, B Braun SE, CODAN US Corp, Baxter International Inc, Elimedical Inc, ICU Medical Inc, BPL Medical Technologies Pvt Ltd, Nipro Corp, KD Scientific Inc, Medtronic Plc, Zimed Healthcare Ltd, Terumo Corp, Eitan Medical Ltd, Polymedicure, Moog Inc, Tandem Diabetes Care Inc.

Based on product type, the infusion devices market is segmented into Infusion Pumps and Infusion Sets. In 2023, the Infusion Pumps segment held the largest share of the market. The infusion pumps segment is further segmented into volumetric pumps, syringe pumps, insulin pumps, patient control analgesia (pca) pumps, enteral pumps, implantable pumps, and elastomeric pumps. The infusion sets segment is further segmented into vented infusion sets and non-vented infusion sets. Based on application, the infusion devices market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. In 2023, the diabetes segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the infusion devices market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Infusion Devices Market are listed below.

In May 2024, Moog Inc. received US FDA 510(k) clearance for CURLIN 8000 Ambulatory Infusion System. This premium infusion platform was developed specifically for use in home infusion settings. The CURLIN 8000 combines a reliable and robust design with a simple, intuitive user interface designed for easy navigation by both clinical and non-clinical users. The CURLIN 8000 also integrates seamlessly with CURLIN RxManager, a completely new medication safety software developed to complement existing home infusion workflows.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Infusion Devices Market Landscape

4.1 PEST Analysis

5. Infusion Devices Market - Key Market Dynamics

5.1 Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Infusion Devices Market - Global Market Analysis

6.1 Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 Infusion Devices Market Forecast Analysis

7. Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

8. Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

9. Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

10. Infusion Devices Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Infusion Devices Market Overview
- 10.2.2 North America: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.2.2.1 North America: Infusion Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.2.2.2 North America: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Pumps
  - 10.2.2.3 North America: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Sets
  - 10.2.2.4 North America: Infusion Devices Market - Revenue and Forecast Analysis - by Application
  - 10.2.2.5 North America: Infusion Devices Market - Revenue and Forecast Analysis - by End User
- 10.2.3 North America: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 North America: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.2 United States: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.2.1 United States: Infusion Devices Market Breakdown, by Product Type
    - 10.2.3.2.2 United States: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.2.3.2.3 United States: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.2.3.2.4 United States: Infusion Devices Market Breakdown, by Application
    - 10.2.3.2.5 United States: Infusion Devices Market Breakdown, by End User
  - 10.2.3.3 Canada: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.3.1 Canada: Infusion Devices Market Breakdown, by Product Type
    - 10.2.3.3.2 Canada: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.2.3.3.3 Canada: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.2.3.3.4 Canada: Infusion Devices Market Breakdown, by Application
    - 10.2.3.3.5 Canada: Infusion Devices Market Breakdown, by End User
  - 10.2.3.4 Mexico: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.4.1 Mexico: Infusion Devices Market Breakdown, by Product Type
    - 10.2.3.4.2 Mexico: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.2.3.4.3 Mexico: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.2.3.4.4 Mexico: Infusion Devices Market Breakdown, by Application
    - 10.2.3.4.5 Mexico: Infusion Devices Market Breakdown, by End User
10.3 Europe
- 10.3.1 Europe Infusion Devices Market Overview
- 10.3.2 Europe: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.3.2.1 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.3.2.2 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Pumps
  - 10.3.2.3 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Sets
- 10.3.3 Europe: Infusion Devices Market Breakdown, by Application
  - 10.3.3.1 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by Application
  - 10.3.3.2 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by End User
- 10.3.4 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.3.4.1 Europe: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.3.4.2 Germany: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.4.2.1 Germany: Infusion Devices Market Breakdown, by Product Type
    - 10.3.4.2.2 Germany: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.3.4.2.3 Germany: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.3.4.2.4 Germany: Infusion Devices Market Breakdown, by Application
    - 10.3.4.2.5 Germany: Infusion Devices Market Breakdown, by End User
  - 10.3.4.3 United Kingdom: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.4.3.1 United Kingdom: Infusion Devices Market Breakdown, by Product Type
    - 10.3.4.3.2 United Kingdom: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.3.4.3.3 United Kingdom: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.3.4.3.4 United Kingdom: Infusion Devices Market Breakdown, by Application
    - 10.3.4.3.5 United Kingdom: Infusion Devices Market Breakdown, by End User
  - 10.3.4.4 France: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.4.4.1 France: Infusion Devices Market Breakdown, by Product Type
    - 10.3.4.4.2 France: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.3.4.4.3 France: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.3.4.4.4 France: Infusion Devices Market Breakdown, by Application
    - 10.3.4.4.5 France: Infusion Devices Market Breakdown, by End User
  - 10.3.4.5 Italy: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.4.5.1 Italy: Infusion Devices Market Breakdown, by Product Type
    - 10.3.4.5.2 Italy: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.3.4.5.3 Italy: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.3.4.5.4 Italy: Infusion Devices Market Breakdown, by Application
    - 10.3.4.5.5 Italy: Infusion Devices Market Breakdown, by End User
  - 10.3.4.6 Spain: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.4.6.1 Spain: Infusion Devices Market Breakdown, by Product Type
    - 10.3.4.6.2 Spain: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.3.4.6.3 Spain: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.3.4.6.4 Spain: Infusion Devices Market Breakdown, by Application
    - 10.3.4.6.5 Spain: Infusion Devices Market Breakdown, by End User
  - 10.3.4.7 Rest of Europe: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.4.7.1 Rest of Europe: Infusion Devices Market Breakdown, by Product Type
    - 10.3.4.7.2 Rest of Europe: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.3.4.7.3 Rest of Europe: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.3.4.7.4 Rest of Europe: Infusion Devices Market Breakdown, by Application
    - 10.3.4.7.5 Rest of Europe: Infusion Devices Market Breakdown, by End User
10.4 Asia Pacific
- 10.4.1 Asia Pacific Infusion Devices Market Overview
- 10.4.2 Asia Pacific: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.4.2.1 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.4.2.2 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Pumps
  - 10.4.2.3 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Sets
  - 10.4.2.4 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by Application
  - 10.4.2.5 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Asia Pacific: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.2 China: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.2.1 China: Infusion Devices Market Breakdown, by Product Type
    - 10.4.3.2.2 China: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.4.3.2.3 China: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.4.3.2.4 China: Infusion Devices Market Breakdown, by Application
    - 10.4.3.2.5 China: Infusion Devices Market Breakdown, by End User
  - 10.4.3.3 Japan: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.3.1 Japan: Infusion Devices Market Breakdown, by Product Type
    - 10.4.3.3.2 Japan: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.4.3.3.3 Japan: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.4.3.3.4 Japan: Infusion Devices Market Breakdown, by Application
    - 10.4.3.3.5 Japan: Infusion Devices Market Breakdown, by End User
  - 10.4.3.4 India: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.4.1 India: Infusion Devices Market Breakdown, by Product Type
    - 10.4.3.4.2 India: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.4.3.4.3 India: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.4.3.4.4 India: Infusion Devices Market Breakdown, by Application
    - 10.4.3.4.5 India: Infusion Devices Market Breakdown, by End User
  - 10.4.3.5 Australia: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.5.1 Australia: Infusion Devices Market Breakdown, by Product Type
    - 10.4.3.5.2 Australia: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.4.3.5.3 Australia: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.4.3.5.4 Australia: Infusion Devices Market Breakdown, by Application
    - 10.4.3.5.5 Australia: Infusion Devices Market Breakdown, by End User
  - 10.4.3.6 South Korea: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.6.1 South Korea: Infusion Devices Market Breakdown, by Product Type
    - 10.4.3.6.2 South Korea: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.4.3.6.3 South Korea: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.4.3.6.4 South Korea: Infusion Devices Market Breakdown, by Application
    - 10.4.3.6.5 South Korea: Infusion Devices Market Breakdown, by End User
  - 10.4.3.7 Rest of APAC: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.7.1 Rest of APAC: Infusion Devices Market Breakdown, by Product Type
    - 10.4.3.7.2 Rest of APAC: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.4.3.7.3 Rest of APAC: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.4.3.7.4 Rest of APAC: Infusion Devices Market Breakdown, by Application
    - 10.4.3.7.5 Rest of APAC: Infusion Devices Market Breakdown, by End User
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Infusion Devices Market Overview
- 10.5.2 Middle East and Africa: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.5.2.1 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.5.2.2 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Pumps
  - 10.5.2.3 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Sets
  - 10.5.2.4 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by Application
  - 10.5.2.5 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by End User
- 10.5.3 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Middle East and Africa: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.2 Saudi Arabia: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.2.1 Saudi Arabia: Infusion Devices Market Breakdown, by Product Type
    - 10.5.3.2.2 Saudi Arabia: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.5.3.2.3 Saudi Arabia: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.5.3.2.4 Saudi Arabia: Infusion Devices Market Breakdown, by Application
    - 10.5.3.2.5 Saudi Arabia: Infusion Devices Market Breakdown, by End User
  - 10.5.3.3 South Africa: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.3.1 South Africa: Infusion Devices Market Breakdown, by Product Type
    - 10.5.3.3.2 South Africa: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.5.3.3.3 South Africa: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.5.3.3.4 South Africa: Infusion Devices Market Breakdown, by Application
    - 10.5.3.3.5 South Africa: Infusion Devices Market Breakdown, by End User
  - 10.5.3.4 United Arab Emirates: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.4.1 United Arab Emirates: Infusion Devices Market Breakdown, by Product Type
    - 10.5.3.4.2 United Arab Emirates: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.5.3.4.3 United Arab Emirates: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.5.3.4.4 United Arab Emirates: Infusion Devices Market Breakdown, by Application
    - 10.5.3.4.5 United Arab Emirates: Infusion Devices Market Breakdown, by End User
  - 10.5.3.5 Rest of Middle East and Africa: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.5.1 Rest of Middle East and Africa: Infusion Devices Market Breakdown, by Product Type
    - 10.5.3.5.2 Rest of Middle East and Africa: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.5.3.5.3 Rest of Middle East and Africa: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.5.3.5.4 Rest of Middle East and Africa: Infusion Devices Market Breakdown, by Application
    - 10.5.3.5.5 Rest of Middle East and Africa: Infusion Devices Market Breakdown, by End User
10.6 South and Central America
- 10.6.1 South and Central America Infusion Devices Market Overview
- 10.6.2 South and Central America: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.6.2.1 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by Product Type
  - 10.6.2.2 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Pumps
  - 10.6.2.3 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by Infusion Sets
  - 10.6.2.4 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by Application
  - 10.6.2.5 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by End User
- 10.6.3 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.6.3.1 South and Central America: Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.6.3.2 Brazil: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.3.2.1 Brazil: Infusion Devices Market Breakdown, by Product Type
    - 10.6.3.2.2 Brazil: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.6.3.2.3 Brazil: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.6.3.2.4 Brazil: Infusion Devices Market Breakdown, by Application
    - 10.6.3.2.5 Brazil: Infusion Devices Market Breakdown, by End User
  - 10.6.3.3 Argentina: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.3.3.1 Argentina: Infusion Devices Market Breakdown, by Product Type
    - 10.6.3.3.2 Argentina: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.6.3.3.3 Argentina: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.6.3.3.4 Argentina: Infusion Devices Market Breakdown, by Application
    - 10.6.3.3.5 Argentina: Infusion Devices Market Breakdown, by End User
  - 10.6.3.4 Rest of South and Central America: Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.3.4.1 Rest of South and Central America: Infusion Devices Market Breakdown, by Product Type
    - 10.6.3.4.2 Rest of South and Central America: Infusion Devices Market Breakdown, by Infusion Pumps
    - 10.6.3.4.3 Rest of South and Central America: Infusion Devices Market Breakdown, by Infusion Sets
    - 10.6.3.4.4 Rest of South and Central America: Infusion Devices Market Breakdown, by Application
    - 10.6.3.4.5 Rest of South and Central America: Infusion Devices Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Financial Overview
- 12.15.4 SWOT Analysis
- 12.15.5 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Tandem Diabetes Care Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About The Insight Partners